ATE54415T1 - Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit. - Google Patents

Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit.

Info

Publication number
ATE54415T1
ATE54415T1 AT85110643T AT85110643T ATE54415T1 AT E54415 T1 ATE54415 T1 AT E54415T1 AT 85110643 T AT85110643 T AT 85110643T AT 85110643 T AT85110643 T AT 85110643T AT E54415 T1 ATE54415 T1 AT E54415T1
Authority
AT
Austria
Prior art keywords
glycoproteins
herpes simplex
simplex virus
subunit vaccine
preparing
Prior art date
Application number
AT85110643T
Other languages
German (de)
English (en)
Inventor
Youichiro Kino
Hiroshi Mizokami
Tetsuo Kawahara
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE54415T1 publication Critical patent/ATE54415T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85110643T 1984-08-24 1985-08-23 Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit. ATE54415T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59177194A JPS6153226A (ja) 1984-08-24 1984-08-24 単純ヘルペスサブユニツトワクチンの精製方法
EP85110643A EP0173268B1 (en) 1984-08-24 1985-08-23 A method for the preparation of a herpes simplex virus subunit vaccine

Publications (1)

Publication Number Publication Date
ATE54415T1 true ATE54415T1 (de) 1990-07-15

Family

ID=16026819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85110643T ATE54415T1 (de) 1984-08-24 1985-08-23 Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit.

Country Status (7)

Country Link
US (1) US4724146A (en, 2012)
EP (1) EP0173268B1 (en, 2012)
JP (1) JPS6153226A (en, 2012)
KR (1) KR920009735B1 (en, 2012)
AT (1) ATE54415T1 (en, 2012)
CA (1) CA1251401A (en, 2012)
DE (1) DE3578617D1 (en, 2012)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
AU2002302069B2 (en) * 1998-03-05 2007-11-15 Cantab Pharmaceuticals Research Limited Virus preparations and methods
US6342384B1 (en) * 1998-08-21 2002-01-29 The University Of Va Patent Foundation Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber system
EP2269639B1 (en) * 2001-02-23 2018-11-28 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
CA2438960A1 (en) * 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
DE10293048T1 (de) * 2001-04-27 2003-07-31 Glaxosmithkline Biolog Sa Neuer Impfstoff
US20070236809A1 (en) 2006-04-05 2007-10-11 Barret Lippey Forming spectral filters
TWI539230B (zh) 2007-05-09 2016-06-21 杜比實驗室特許公司 三維影像之投影與觀看系統（一）
US7784938B2 (en) 2007-05-09 2010-08-31 Dolby Laboratories Licensing Corporation Method and system for shaped glasses and viewing 3D images
US7959295B2 (en) 2007-05-18 2011-06-14 Dolby Laboratories Licensing Corporation Spectral separation filters for 3D stereoscopic D-cinema presentation
DE102013017014B4 (de) 2013-10-14 2017-03-30 Sartorius Stedim Biotech Gmbh Sulfatierte Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung der Membran als Adsorptionsmembran für die Virenaufreinigung
US10809543B2 (en) 2017-01-23 2020-10-20 Dolby Laboratories Licensing Corporation Glasses for spectral and 3D imaging
CN111896731B (zh) * 2020-06-24 2023-06-09 宁波瑞源生物科技有限公司 一种化学发光免疫分析用清洗液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen

Also Published As

Publication number Publication date
EP0173268B1 (en) 1990-07-11
US4724146A (en) 1988-02-09
DE3578617D1 (de) 1990-08-16
EP0173268A2 (en) 1986-03-05
EP0173268A3 (en) 1986-05-28
JPS6153226A (ja) 1986-03-17
KR870001837A (ko) 1987-03-28
JPH0463863B2 (en, 2012) 1992-10-13
KR920009735B1 (ko) 1992-10-22
CA1251401A (en) 1989-03-21

Similar Documents

Publication Publication Date Title
ATE54415T1 (de) Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit.
DE3165561D1 (en) Semipermeable composite membranes comprising modified polyvinyl alcohol, process for their preparation and their use
ES525361A0 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
PT70542A (en) Process for preparing amino acid derivatives as antihypertensives
ES522512A0 (es) Un procedimiento de preparar un liposoma recubierto que contiene ubidecarenona.
DE3789435D1 (de) Verfahren zur Herstellung von Eicosapentaensäure.
DK0550509T3 (da) Fremgangsmåde til fremstilling af rensede glycolipider ved membranseparationsmetoden
EP0171765A3 (en) A method for purification of japanese encephalitis virus
FI873689A7 (fi) Menetelmä hartsiesterien valmistamiseksi.
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
GB2020299B (en) Ultrafiltration membranes and the process for ultrafiltration membranes and the process for their preparation
BE881082A (nl) Werkwijze voor de bereiding van geconcentreerde natuurazijn en werkwijze voor de bereiding van azijnzuuresters
DE3585713D1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
DE69020119D1 (de) Verfahren zur Herstellung von hochreiner Naphthalin-2,6-Dicarbonsäure.
IL64850A0 (en) Process for the preparation of optically active 2-chloropropionic acid esters
DE3462269D1 (en) Low alcohol beer and process for its preparation
DE59300921D1 (de) Verfahren zur Herstellung von beta-Hydroxycarbonsäureestern.
DE58908067D1 (de) Verfahren zur Herstellung konzentrierter Lösungen kationischer Farbstoffe.
DE69103913D1 (de) Verfahren zur Herstellung von Dodekandicarbonsäure.
ES447851A1 (es) Un procedimiento para la produccion de un preparado farmaco-logico que tiene accion anticoagulante "in vivo".
DE2963740D1 (en) (4-fluoro-3-phenoxy-alpha-cyanobenzyl)esters of 3-chlorostyryl-2,2-dimethyl-cyclopropanoic acid, method of preparation and use as ectoparasiticides
DE68916181D1 (de) Verfahren zur Herstellung von Polyglycidylethern.
DE69304634D1 (de) Verfahren zur Herstellung von N,O-Dialkylhydroxycarbaminsäureestern
DE3060550D1 (en) Process for the preparation of 2-formyl-3.3-dimethyl-cyclopropanecarboxylic acid esters
DE3161413D1 (en) N-phenylphosphoramidate esters, process for their preparation and their use as coupling components

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties